Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Robert R, Verbrugge"'
Autor:
Robert R. Verbrugge
Publikováno v:
Cognition and Figurative Language ISBN: 9780429432866
Metaphor is, at root, a problem of knowing. It can serve a crucial role in the development of knowing, both for an individual and for a community. It is a powerful vehicle for recasting identity, for apprehending structure in novel ways. While metaph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c6fd538ea0746a7e78b38e208cc6bab
https://doi.org/10.4324/9780429432866-5
https://doi.org/10.4324/9780429432866-5
Autor:
Felix W. Frueh, Ronald E. Aubert, Barnabie C Agatep, Robert R. Verbrugge, A Patel, K A Johansen Taber, C. Sanders, Mona Khalid, Edward J. Stanek, Robert S. Epstein
Publikováno v:
Clinical Pharmacology & Therapeutics. 91:450-458
To develop a benchmark measure of US physicians' level of knowledge and extent of use of pharmacogenomic testing, we conducted an anonymous, cross-sectional, fax-based, national survey. Of 397,832 physicians receiving the survey questionnaire, 10,303
Autor:
Brian F. Gage, Robert R. Verbrugge, J. Russell Teagarden, Thomas P. Moyer, Robert S. Epstein, Ronald E. Aubert, Fang Xia, Dennis J. O'Kane
Publikováno v:
Journal of the American College of Cardiology. 55(25):2804-2812
Objectives: This study was designed to determine whether genotype testing for patients initiating warfarin treatment will reduce the incidence of hospitalizations, including those due to bleeding o...
Autor:
Robert S. Epstein, Robert R. Verbrugge, Lawrence J. Lesko, Gilbert J. Burckart, Teresa M. DeLuca, Felix W. Frueh, Ronald E. Aubert, Padmaja Mummaneni, Shashi Amur
Publikováno v:
Pharmacotherapy. 28:992-998
Study Objectives. To review the labels of United States Food and Drug Administration (FDA)-approved drugs to identify those that contain pharmacogenomic biomarker information, and to collect prevalence information on the use of those drugs for which
Publikováno v:
Journal of Attention Disorders. 10:335-342
Objective: This study examines demographic trends in the use of medications to treat ADHD in adult and pediatric populations. Method: Using pharmacy claims data for a large population of commercially insured Americans, the study measures ADHD treatme
Autor:
Mona Khalid, Richard A. Feifer, Ronald E. Aubert, Rebecca Levin, Gwendolyn B. O’Keefe, Robert R. Verbrugge
Publikováno v:
Disease Management & Health Outcomes. 12:93-102
In day-to-day practice, asthma treatment and self-management often fall short of the objectives defined by clinical practice guidelines. The objective of this study was to determine whether a population-based asthma disease management program, using
Publikováno v:
Disease Management. 5:143-156
Chronic obstructive pulmonary disease (COPD) is a highly prevalent condition with broad economic impacts. It presents a major opportunity for healthcare cost reduction and improved functional status. This study measures the gaps between current treat
Publikováno v:
Journal of Managed Care Pharmacy. 7:460-467
OBJECTIVE: To evaluate the impact of an asthma disease management program conducted by a pharmacy benefit management (PBM) organization. DESIGN: A prospective analysis of the outcomes of an education-based disease management program for a large popul
Autor:
Robert R Verbrugge, Marie Manteuffel, Amy Steinkellner, Donald G Pittman, Sophy Williams, William Chen
Publikováno v:
Journal of women's health (2002). 23(2)
This study evaluates the differences between women and men in medication use, medication adherence, and prescribing alignment with clinical guidelines.We conducted an analysis of pharmacy and medical claims for 29.5 million adults with prescription b
Autor:
Robert S, Epstein, Thomas P, Moyer, Ronald E, Aubert, Dennis J, O Kane, Fang, Xia, Robert R, Verbrugge, Brian F, Gage, J Russell, Teagarden
Publikováno v:
Journal of the American College of Cardiology. 55(25)
This study was designed to determine whether genotype testing for patients initiating warfarin treatment will reduce the incidence of hospitalizations, including those due to bleeding or thromboembolism.Genotypic variations in CYP2C9 and VKORC1 have